Alleged medication violation of Todd Pletcher-trained colt occurred in racing debut at Gulfstream Park in December ...

Corporation (market cap: $2.7 billion) reported its fourth-quarter 2024 earnings, surpassing Wall Street expectations with an EPS of $0.63 against the forecasted $0.58. Revenue also exceeded ...

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...

Equinix forecast first-quarter and annual revenue below estimates on Wednesday, hurt by a strong dollar amid rising concerns ...

Q3 2025 Earnings Call Transcript February 11, 2025 Jerash Holdings (US), Inc. beats earnings expectations. Reported EPS is ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a ...

In the fourth quarter of 2024, the Income tax provision was $125.7 million on income before income taxes of $483.3 million.

The co-extrusion of this demonstration coupon sample represents a key fabrication milestone under Lightbridge's Strategic ...

Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 PatientsSHIELD II Enrolled more than ...

While 92 per cent of Canadians in a relationship reported being “very” or “somewhat” content, only 73 per cent said they were ...